#ASCP2023

#ASCP2023

#ASCP2023

#ASCP2023

#ASCP2023

#ASCP2023

#ASCP2023

Illustration of a rare case of intravascular large B-cell lymphoma with "anaplastic features", this variant is previously described, the cells are more pleomorphic than the typical large immunoblastic presentation #dermpath , these cases go to you first typically & the

Have you had a pediatric B-ALL with very mature features previously, that made you question whether you are dealing with a B-cell lymphoma instead? Below is a similar case: Starting with CD38 expression: It is not as "dim" as you would expect it to be in B-ALL #Hemepath #Leusm

Interested in unpacking the FDA's final rule on Laboratory Developed Tests? Our expert panelists help you navigate this new regulatory landscape and address any questions during this virtual town hall meeting at 12 PM CST on May 21. Register now: bit.ly/4baIxxn

#LDTs and #FDAoversight have been a major talking point in the laboratory world for the last couple of months. Join the experts from ASCP to discuss what this means for your laboratory on May 21st!

Incredibly important discussion!

#GUpath TURBT: urothelial carcinoma with trophoblastic differentiation (paired #IHCpath is HCG)

#ASCP2024

#ASCP2024 Day 2 kicking off with #neuropath #molpath #moldx combo! Excellent discussion on the applications of molecular in neuro! #pathtwitter #pathX

#ASCP2024

#ASCP2024

#ASCP2024

#ASCP2024

🎉#JI_TopRead ➡️ This study by Pratik Deb, MD, PhD et al. reveals the effects of TLR10 expression in primary #human pDCs. #ReadTheJI #immunology Patricia Fitzgerald-Bocarsly Read here what this means for innate responses: ow.ly/HHVu50TgPNC